Replay available

Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 Earnings Call

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Q2 2025 earnings conference call, held 2025-08-11. Replay captured from the company's public earnings webcast.

Mon, August 11, 2025 at 4:30 PMendedReplay
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 Earnings Call

Hosted by

Featured presenters

Netta Safarzadeh

Vice President, Head of Investor Relations, Public Relations & Marketing

Joe Payne

President and CEO

Andy Sassine

Chief Financial Officer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcturus Therapeutics Holdings Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.056 Good day, everyone, and welcome to the Arcturus Therapeutics Second Quarter 00:00:05.056 -- 00:00:07.939 2025 Earnings Call. 00:00:07.939 -- 00:00:12.363 At this time, all participants are in a listen-only mode. 00:00:12.363 -- 00:00:16.207 Later, you will have the opportunity to ask questions during the question and answer 00:00:16.207 -- 00:00:18.207 session. 00:00:18.249 -- 00:00:24.095 You may register to ask questions by pressing the star and 1 on your telephone keypad. 00:00:24.095 -- 00:00:28.199 You may withdraw your question by pressing star 2. 00:00:28.199 -- 00:00:32.239 Please note, this call is being recorded. and that will be standing by should you need 00:00:32.239 -- 00:00:34.419 any assistance. 00:00:34.502 -- 00:00:39.508 It is now my pleasure to turn the conference over to Netta Safarzadeh, Vice 00:00:39.508 -- 00:00:43.954 President, Head of Investor Relations, Public Relations Marketing. 00:00:43.954 -- 00:00:46.354 Please go ahead. 00:00:46.377 -- 00:00:52.064 Thank you, Operator. Good afternoon and welcome to Arcturus Therapeutics Quarterly Financial 00:00:52.064 -- 00:00:57.711 Update and Pipeline Progress Call. Today's call will be led by Joe Payne, 00:00:57.711 -- 00:01:02.622 our President and CEO. and Andy Sassine, our CFO. 00:01:02.622 -- 00:01:07.788 Dr. Pat Chivakula, our CSO and COO, will join them for the Q&A 00:01:07.788 -- 00:01:09.450 session. 00:01:09.450 -- 00:01:13.675 Before we begin, I would like to remind everyone that the statements made during this 00:01:13.675 -- 00:01:19.042 call regarding matters that are not historical facts are forward-looking statements 00:01:19.042 -- 00:01:24.008 within the safe harbor provisions of the Private Securities Litigation Reform Act of 00:01:24.008 -- 0...